Corporate Finance

Ultragenyx's stock plummets after its Osteogenesis Imperfecta drug fails to reduce fractures, a major blow for patients and a test of the firm's pipeline.

Rokid's new 'Style' line bets on affordability and design to bring AI wearables to the masses, building on proven tech and a rapidly growing open ecosystem.

Ethical food leader Vital Farms heads to the ICR Conference with record profits and a $2B goal, ready to prove its model can win against new competition.

INOVIO's promising non-surgical treatment for a rare disease faces FDA scrutiny, casting doubt on its fast-track approval and impacting patient hopes.

Purina Foundation's 2025 grants extend beyond animal welfare, funding disaster relief, youth education, and veteran support in a strategic philanthropic push.

Genmab discontinues its 'encouraging' lung cancer drug, acasunlimab, in a bold strategic pivot to accelerate its most promising late-stage assets.

A Korean pet food brand's surprise win over tech giants at a top pitch event signals a major shift in what venture capitalists value. Here's why.

A Chinese manufacturer is solving a global branding puzzle, merging bespoke craftsmanship with industrial scale through a unique 'MaaS' production model.

Professional Diversity Network invests millions in an AI crypto token, a risky move signaling a dramatic pivot into the volatile world of Web3 finance.

Chip Wilson nominates three directors in a bid to remake Lululemon's board, criticizing its leadership and demanding a return to product innovation.

Verisk terminates its $2.35B AccuLynx acquisition after FTC delays, triggering a $1.5B debt redemption and a potential legal battle with the spurned firm.

A pivotal trial for an acute myeloid leukemia drug is delayed for a promising reason: patients are surviving longer than anticipated, fueling cautious optimism.

The InsurTech firm is shedding non-core units to slash debt by over 50% and double down on its AI platforms, RELI Exchange and 5minuteinsure.com.

Sofie Biosciences begins late-stage trials for a novel PET scan targeting aggressive gastrointestinal cancers, a breakthrough that could redefine detection.

As 374Water pushes its waste-destroying tech to market, a new board member with deep financial expertise and a history as a long-term investor joins.

The cleantech firm hits key milestones in German and Italian energy projects while its unconventional portfolio expands into biotech and agritech.

Chinese cloud firm Cloopen forms a special committee to eye a go-private deal from its own CEO, putting shareholder value and corporate governance in the spotlight.

Core AI divests its cash-burning Siyata Mobile hardware unit just months after merging, betting its future entirely on AI-powered gaming and content.

A Korean AI startup raised $854K for a gesture-control ring, betting its enterprise-grade tech can unlock the future of post-touch computing.

The specialty construction firm closes a major refinancing deal, slashing borrowing costs and unlocking capital for acquisitions and expansion.